Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer.

Inclusion Criteria: * Age ≥ 18 years old * Patient with breast carcinoma * Patients treated with adjuvant chemotherapy (FEC + 3 docetaxel +/- Herceptin®) * Patients who have never been treated with taxanes * Patients with no nail damage before starting the study * ECOG performance \< 2 * Ability to provide written informed consent Exclusion Criteria: * Patient allergic to any of the treatment components * Use of film-forming solution, solvents or any other products applied to the fingernails (artificial nails ...) in three weeks before the first of docetaxel treatment * Risk of exposure to aggressive factors nail during the study * Using refrigerants gloves during chemotherapy treatments * Onychophagia * Presence of nail disease or a history of nail pathology (infectious and other) * Pregnant or breast feeding females * Patients whose condition is not compatible with the follow-up study